Long Gu (Os Draconis): Textual research, modern scientific evaluation, and quality control challenges.
Clinical Snapshot
PICO Framework
| P — Population | Traditional Chinese medicine practitioners and patients using Long Gu (Os Draconis) preparations |
| I — Intervention | Quality control frameworks and authentication methods for Long Gu |
| C — Comparator | Current pharmacopoeial standards based solely on calcium content |
| O — Outcomes | Authentication accuracy, safety profile, therapeutic efficacy, and sustainable sourcing |
Bottom Line
This systematic review identifies critical quality control gaps in Long Gu (Os Draconis), a traditional Chinese mineral medicine facing widespread adulteration and resource depletion. The authors propose moving beyond simple calcium content testing to comprehensive authentication using paleontological origin verification, microstructural analysis, and chemical fingerprinting. While the historical analysis is thorough and the proposed framework scientifically sound, the review lacks rigorous systematic methodology and validation studies. The findings highlight broader challenges in traditional medicine quality control but have limited direct applicability to mainstream Australian clinical practice. The work serves more as a foundation for regulatory reform in traditional medicine markets than immediate clinical guidance.
Key Findings
Effect Size: Not applicable - qualitative review
Primary Outcome: Authentic Long Gu identified as carbonated hydroxyapatite with >35% porosity and specific trace element profile
Nnt Or Sensitivity: Market adulteration rate not quantified but described as widespread
Confidence Interval: Not reported
Clinical Application
Implementation requires specialized analytical equipment and expertise in paleontology/geochemistry Limited relevance to Australian practice as Long Gu not commonly used; however, principles applicable to TGA regulation of imported traditional medicines and quality control frameworks Traditional Chinese medicine practitioners and regulatory bodies overseeing herbal medicines
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: Long Gu (Os Draconis), a mineral medicine with over 2000 years of use in traditional Chinese medicine, is facing a critical juncture. Its identity has been clarified scientifically-from a mythologized "dragon bone" to a fossilized mammalian bioapatite-yet its sustainable clinical application is threatened by resource depletion, widespread domestic and international adulteration, and the lack of modern quality standards. AIM OF THE STUDY: This review aims to systematically analyze the evolution of Long Gu through historical materia medica, define its authentic characteristics using modern science, diagnose the root causes of its current market and regulatory crisis, and propose a robust, multi-dimensional framework for quality evaluation and sustainable sourcing. MATERIALS AND METHODS: A systematic review of Chinese materia medica literature from the Pre-Qin to Qing Dynasties was conducted. Historical textual research was integrated with evidence from modern mineralogy, paleontology, geochemistry, and pharmacology to validate traditional knowledge and establish scientific identification criteria. RESULTS: The understanding of Long Gu evolved from mythological origins to a scientific conclusion in the Ming Dynasty, with Li Shizhen correctly identifying it as fossilized ancient mammalian bones. Modern research confirms authentic "Wuhua Long Gu" from the Shanxi-Shaanxi region is primarily carbonated hydroxyapatite, characterized by high porosity (>35%), significant hygroscopicity, and a unique trace element profile (Zn, Sr). These properties underpin its advertised therapeutic effects. However, the market is now saturated with dangerous adulterants, including fluoride-rich dinosaur fossils and processed modern bones, due to resource exhaustion and inadequate pharmacopoeial standards focused solely on calcium content. CONCLUSION: The future of Long Gu depends on transcending outdated quality controls. Ensuring its efficacy and safety necessitates a paradigm shift to a comprehensive standard system that combines paleontological and geochronological origin verification, quantitative microstructural analysis, chemical fingerprinting of key components, and strict safety monitoring. Complementary research into biomimetic synthesis and accelerated mineralization is urgently needed to develop sustainable alternatives for this invaluable yet endangered medicinal resource.
References
- 1.Sun, X., Li, Z. H., Gao, Y., Kumar, G., Liu, J., Li, L., Zhang, C., & Chen, J. (2026). Long Gu (Os Draconis): Textual research, modern scientific evaluation, and quality control challenges. Journal of Ethnopharmacology, 121354. https://doi.org/10.1016/j.jep.2026.121354
Related Research
Journal of integrative medicine
Deep learning in traditional Chinese medicine
1 July 2026
Medicine
Efficacy and safety of traditional Chinese medicine decoctions as an adjuvant treatment for rheumatoid arthritis: A systematic review and meta-analysis
28 June 2026
Journal of ethnopharmacology
Revealing the temporal metabolic trajectory and potential pharmacodynamic substances of Da-Cheng-Qi Decoction in treating patients with acute pancreatitis: A serum metabolomics-based study
12 June 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service